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Parathyroid hyperplasia in uremic rats precedes
down-regulation of the calcium receptor
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Parathyroid hyperplasia in uremic rats precedes down-regula- attention. The systemic factors involved in the pathogen-
tion of the calcium receptor. esis of parathyroid hyperplasia include decreases in se-
Background. Recent evidence points to a relationship between rum calcium and 1,25-dihydroxyvitamin D3, and an increasethe down-regulation of the calcium-sensing receptor (CaR)
in serum phosphorus. Down-regulation of both the cal-and parathyroid cell hyperplasia that is associated with chronic
renal failure. It is not known, however, if down-regulation of the cium-sensing receptor (CaR) and the vitamin D receptor
CaR precedes, and perhaps initiates, parathyroid cell prolifera- (VDR) in hyperplastic PTGs of uremic patients have
tion, or if a decrease in the expression of the CaR occurs subse- been reported, and also may be involved in the pathogen-quently to hyperplasia or the conditions promoting it. The current
esis of parathyroid hyperplasia [1–6].study examined the temporal relationship of these two events.
Methods. Rats were made uremic by subtotal nephrectomy We recently have examined the association between
and were (1) placed immediately on a high phosphate (HP) diet CaR expression and parathyroid cell proliferation in a
that promotes parathyroid gland hyperplasia, or (2) maintained uremic rat model [7]. We found that down-regulation ofon a low phosphate (LP) diet that inhibits development of sec-
the CaR occurred in chronic renal failure, but only whenondary hyperparathyroidism before being switched to the HP
the PTGs were hyperplastic. Restriction of dietary phos-diet. Serum chemistries and parathyroid gland (PTG) weights
were examined; CaR content and parathyroid cell proliferation phate, which inhibits parathyroid cell hyperplasia, pre-
(PCNA/Ki-67) were analyzed by immunohistochemistry. vented down-regulation of the CaR. In addition, areas
Results. When rats were nephrectomized and placed imme-
of decreased CaR protein expression were associateddiately on a HP diet, parathyroid cell proliferation was signifi-
with areas of parathyroid cell proliferation. This associa-cantly increased by day 2 and continued to increase at day 4.
CaR content was unchanged at 1 and 2 days post-nephrectomy, tion between CaR expression and parathyroid cell prolif-
but fell by day 4. When nephrectomized rats were maintained eration also has been demonstrated in vitro. We and
for 1 week on a LP diet, then switched to a HP diet, an increase
others have shown that the rapid loss of calcium responsein parathyroid cell proliferation was again seen at day 2; down-
in monolayer cultures of proliferating bovine parathy-regulation of the CaR did not occur until after 7 days of uremia
and the HP diet. roid cells is associated with a dramatic decrease in the
Conclusion. These data indicate that parathyroid cell hyper- expression of CaR mRNA and protein [8, 9]. The specu-
plasia precedes down-regulation of CaR expression in the ure-
lation that down-regulation of the CaR could be a func-mic rat model.
tion of the proliferative or dedifferentiated state of hy-
perplastic parathyroid cells is supported by Nygren et al,
who found that proliferating bovine parathyroid mono-Excess secretion of parathyroid hormone (PTH) and
layers exhibited a decreased suppressibility of PTH byenlargement of the parathyroid glands (PTGs) are hall-
calcium, whereas non-proliferating cells retained muchmarks of secondary hyperparathyroidism (2HPT), a com-
of their ability to regulate secretion of PTH [10].plication frequently associated with chronic renal failure.
Although an association between CaR down-regula-While much has been learned in the past decade about
the control of PTH secretion, the importance of regula- tion and parathyroid hyperplasia is apparent, the full
tion of parathyroid gland size has recently gained more nature of their temporal relationship is unclear. In es-
sence, does the decline in CaR content occur as an early,
perhaps initiating, event in the development of parathy-Key words: calcium-sensing receptor, parathyroid hyperplasia, uremia,
chronic renal failure, secondary hyperparathyroidism. roid hyperplasia, or does it occur subsequently to para-
thyroid cell proliferation or the conditions that promote
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METHODS goat serum and incubated with an IgG fraction of the pri-
mary antibody (6.4 g/mL) or pre-immune IgG (6.4 g/Animals and diets
mL) for one hour at room temperature. Biotinylated
Renal insufficiency was induced in female Sprague- secondary antibody was applied, followed by a streptavi-
Dawley rats by 5/6 nephrectomy. This procedure in- din-horseradish peroxidase conjugate. The immune com-
volves ligation of most of the branches of the left renal plexes were visualized with AEC substrate-chromagen.
artery followed by right nephrectomy. In protocol 1, Immunostaining of the CaR protein was quantified
rats made uremic were placed immediately on a high using a Nikon Diaphot-TMD microscope coupled to a
phosphate diet (HP; 0.9% P, 0.6% Ca) that promotes camera and an image analysis system. Images of stained
secondary hyperparathyroidism, and then studied at 1, tissue sections (100 magnification) were acquired using
2, 4 and 7 days. In protocol 2, rats made uremic were a DAGE-330 color camera and captured with a Pentium
placed for 1 week on a low phosphate diet (LP; 0.2% P, P-166 IBM-compatible computer equipped with a Co-
0.5% Ca) that inhibits development of secondary hyper- reco frame-grabber. The digitized images were converted
parathyroidism, and then switched to a HP diet (1.2% P, to gray scale and analyzed using Image-Pro Plus software
0.5% Ca) for 0, 1, 2, 3, 4, 7 and 14 days. Control (intact) (Media Cybernetics, Silver Spring, MD, USA). All com-
rats in each experiment were fed a normal chow diet. ponents were obtained from Boyce Scientific, Inc. (St.
At each time point, the animals were exsanguinated Louis, MO, USA). The intensity of staining of the CaR
by aortic puncture and the blood analyzed for clinical was then quantified using the optical density function of
determinations. The PTGs were weighed and fixed in the software. The average optical density per section of
10% formalin for subsequent immunostaining. Diets tissue was calculated by dividing the sum integrated opti-
were obtained from Dyets, Inc (Bethlehem, PA, USA). cal density by the sum area. Background staining (the
The Animal Studies Committee of Washington Univer- average optical density of the negative control tissue)
sity approved all animal protocols. was subtracted from this value. Approximately 6 to 10
sections of tissue from each parathyroid gland were im-Clinical determinations
munostained. On each day of immunostaining, tissue
Plasma ionized calcium was measured using a specified sections from 3 to 5 animals per experimental group were
electrode (Model ICA-1; Radiometer, Copenhagen, Den- analyzed together. The optical densities of the staining
mark). Serum creatinine and phosphorus were determined intensities from each of the animals in the experimental
by an autoanalyzer (COBAS MIRA Plus, Branchburg, groups were calculated as a percentage of optical densi-
NJ, USA). Serum PTH was measured by an immunora- ties obtained from control animals for that day of stain-
diometric assay specific for intact rat PTH (Immutopics, ing. The percentages obtained for any one animal on
San Clemente, CA, USA). Parathyroid glands were different days of staining were then averaged, resulting
weighed on a microbalance (CAHN C-31; CAHN Instru- in a single value per animal. The coefficients of variation
ments, Inc., Cerritos, CA, USA) and results reported as for the groups in which CaR immunostaining was mea-
a ratio of g gland weight per gram body weight. sured averaged 22.8  2.7% (SEM); therefore, a 20%
change (lower limit) in CaR could be detected statisti-
Immunohistochemistry cally with confidence using this method. The Student
Calcium-sensing receptor protein in the rat parathy- unpaired t test was used for statistical evaluation.
roid glands was measured by immunostaining and quan- To examine parathyroid cell proliferation, sections of
tified by computer-assisted image analysis as previously PTGs were immunostained for proliferative cell nuclear
described [7]. Briefly, immunostaining was performed antigen (PCNA) and/or Ki-67, two proteins that are found
on formalin-fixed, paraffin-embedded parathyroid glands in the nuclei of dividing cells. While PCNA has been
using our primary antibody and a commercial staining widely used for many years as an indicator of cell prolif-
kit (Histostain-Plus, rabbit; Zymed Laboratories, Inc., eration, Ki-67 is becoming more accepted as a superior
South San Francisco, CA, USA). An IgG fraction of a marker of proliferation. Not only is Ki-67 tightly associa-
polyclonal antibody developed in rabbit against a 23- tion with the cell cycle, it is not found in non-cycling cells or
amino acid peptide (“ADD” peptide) contained in the in cells that are undergoing DNA repair, and its expression
extracellular domain of the CaR that is conserved in decreases rapidly after mitosis. Briefly, after deparaffin-
human, bovine, and rat (Research Genetics, Huntsville, ization and rehydration, PCNA and Ki-67 antigens were
AL, USA) was used as the primary antibody. Non-spe- unmasked by microwaving the slides in 10 mmol/L citric
cific staining (negative control) was obtained by substi- acid, pH 6.0 for 14 minutes at high power (1100 watts)
tuting rabbit pre-immune IgG for the primary antibody. using a Sharp Carousel microwave. After cooling at room
The tissue was deparaffinized, rehydrated, and endoge- temperature for 10 minutes, the slides were processed
nous peroxidase quenched using 0.6% hydrogen peroxide using anti-PCNA primary antibody (PC10; Zymed Labo-
ratories) and mouse Ki-67 primary antibody (MIB-5;in methanol. Tissue was blocked with 10% pre-immune
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Table 1. Serum chemistries: Protocol 1
Creatinine ICa P
PTH PTG/body wt
Groups N mg/dL pg/mL lg/g
Controls 10 0.770.05 4.510.09 6.920.73 4126 0.760.08
1 day HP 10 2.180.31a 4.290.18a 8.351.96b 190113a 0.890.30
2 days HP 7 1.740.21a 4.550.21 6.360.50 8737a 0.840.26
4 days HP 10 1.570.44a 4.440.16 9.091.64a 10146a 1.080.37a
7 days HP 8 1.250.15a 4.470.12 9.251.51a 23083a 1.150.30a
Rats were made uremic and placed immediately on a high phosphate (HP) diet for 7 days. Intact control rats were fed a normal chow diet. Data are expressed
as mean  SD. Abbreviations are: ICa, ionized calcium; P, phosphorus; PTH, parathyroid hormone; PTG, parathyroid gland.
a P  0.01, b P  0.05 compared to control values
Beckman Coulter, Inc., Fullerton, CA, USA) with a com- RESULTS
mercial staining kit (Histostain-Plus mouse kit; Zymed Protocol 1
Laboratories) per the manufacturer’s instructions. One Rats made uremic were placed immediately on a HP
to two slides, each consisting of one to two sections of diet for 1, 2, 4 and 7 days; intact control rats were fed a
rat parathyroid tissue, were assayed per nuclear antigen normal chow diet. Serum chemistries, PTH and PTG
per animal. To insure objectivity, counting of positive weights are shown in Table 1. Of particular interest were
nuclei was performed in a “blind” fashion, that is, the fluctuations of the parameters measured (except PTG
label on each slide was covered with opaque tape, leaving weight) at 1 day post-nephrectomy. Most likely these
the observer unaware of which experimental group was could be attributed to the stress of surgery, as both ion-
being counted. For Ki-67, all clearly stained nuclei were ized calcium (ICa) and P levels returned to normal levels
designated as positive. For PCNA, heavily stained nuclei by day 2, and the increases in PTH and creatinine levels
were designated as positive as determined by the ob- were not as extreme at day 2. Nephrectomized rats at
server. Quantification of parathyroid cell proliferation each time point exhibited uremia as indicated by signifi-
was obtained by counting the total number of Ki-67- or cant increases in serum creatinine levels compared with
PCNA-positive nuclei in the entire section of tissue. This controls. Serum phosphorus levels were elevated at 1
value was then divided by the area of the entire section day post-nephrectomy compared with controls, returned
of tissue (as obtained from a digitized computer image to normal levels at 2 days of uremia and then significantly
using the Image-Pro Plus software described above), giving increased at 4 and 7 days of uremia. Ionized calcium
a value of the number of positive nuclei per unit area levels in uremic rats, despite an initial decrease at 1 day,
(1000 pixels). Quantitating in this manner, in which the were not different from controls at 2, 4 and 7 days of
total number of nuclei stained for PCNA/Ki-67 in the en- uremia. PTH levels in nephrectomized rats were elevated
tire section of tissue is corrected by the area of the entire at day 1 and remained higher than controls for the dura-
section of tissue, provides a direct evaluation of overall tion of the time course. Parathyroid gland weights at 1
cell proliferation in that tissue section, not just in ran- and 2 days of uremia were not different from controls,
domly selected areas. On each day of staining, the num- but were significantly higher at 4 and at 7 days of uremia.
ber of PCNA- or Ki-67-positive cells per unit area for Cell proliferation (PCNA) and CaR content were ex-
each animal in each experimental group was reported amined by immunohistochemical staining of sections of
as the percent of control values obtained on that day. formalin-fixed, paraffin-embedded parathyroid glands.
(As an example, one rat on the high phosphate diet for Representative images of the time courses showing the
2 days had 85 positive Ki-67 nuclei in the entire cross- increase in cell proliferation in relation to the fall in CaR
section of tissue; the area of that cross-section of tissue expression are shown in Figure 1. PCNA-positive cells
was 22,791 pixels. Therefore, it had a labeling index of exhibited punctate staining of the nuclei, which increased
3.73 nuclei per unit area of 1000 pixels. Compare this to early in the time course. CaR expression in the controls
a normal rat that had 14 positive Ki-67 nuclei per 15,837 and at days 1 and 2 post-nephrectomy was homogeneous,
pixels, which resulted in a labeling index of 0.884 nuclei but was decreased and more heterogeneous at 4 and 7
per unit area of 1000 pixels. The labeling index for each days of uremia and a HP diet.
experiment rat was compared to the labeling index of the Quantification of parathyroid cell proliferation was
control rats and reported as % control). The percentages obtained by counting the total number of PCNA-positive
obtained for any one animal on different days of staining nuclei in the entire section of tissue; this value was di-
were then averaged, resulting in a single value per ani- vided by the area of that tissue as obtained from a digi-
mal. The Student unpaired t test was used for statistical tized computer image using the Image-Pro Plus software.
The number of PCNA-positive cells per unit area wasevaluation.
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Fig. 1. Representative images of the changes
in proliferative cell nuclear antigen (PCNA) and
calcium-sensing receptor (CaR) expression in
uremic rats maintained on a high phosphate diet
that promotes parathyroid hyperplasia. PCNA
and CaR content were examined by immuno-
histochemical staining of sections of formalin-
fixed, paraffin-embedded parathyroid glands
(magnification, PCNA 400, CaR 100).
then reported as the percent of control values. Quantifi- of controls, and then to 61  19% at 7 days of uremia.
These data indicate that parathyroid cell proliferationcation of the CaR immunostaining was performed by
computer assisted image analysis and reported as percent precedes the down-regulation of the CaR in uremic rats.
of control values. As shown in Figure 2, an increase in
Protocol 2cell proliferation was observed early in uremia: PCNA
immunostaining at 2 days of uremia was 2.4-fold higher In the initial experiment, rats were nephrectomized
and placed immediately on a high phosphate diet. Whilethan controls and remained elevated throughout the time
course. CaR content at 1 and 2 days of uremia was not this initiated a rapid proliferative response and down-
regulation of the CaR in the parathyroid gland, it ren-different from controls. However, by 4 days of uremia,
the CaR content had significantly dropped to 63  22% dered the individual effects of uremia and phosphate
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proliferation was observed rapidly after uremic rats were
switched to the HP diet: PCNA immunostaining at 2
days on the HP diet was 2.4-fold higher than controls,
and 3.7-fold higher at 3 days. This increase in parathyroid
cell proliferation at 2 days was verified by immunostain-
ing for Ki-67, another nuclear antigen associated with cell
proliferation. Ki-67 immunostaining was within normal
levels at 1 day on the HP diet, but increased significantly
at 2 days (3.3-fold higher than controls, P  0.0001) and
remained significantly elevated at 3 days on the HP diet
(2.6-fold higher, P 0.001). Parathyroid gland CaR con-
tent of uremic rats on the LP diet (day 0) was not differ-
ent from controls; CaR content of uremic rats switched
to the HP diet remained within control levels through 7
days, but was down-regulated by 14 days. Therefore, in
Fig. 2. Time course of changes in PCNA () and CaR () expression protocol 2, we again found that cell proliferation in ure-for protocol 1. Rats were made uremic and placed immediately on a
mic rats on a HP diet, as assessed by both PCNA and Ki-high phosphate (HP) diet that promotes parathyroid hyperplasia. Intact
control rats (day 0) were fed a regular chow diet. CaR protein content 67, increased very early in uremia and preceded down-
was assessed by immunohistochemical staining and quantified by com- regulation of the CaR.puter-assisted analysis and reported as optical density, % of control
values. Cell proliferation was determined as the number of PCNA-
positive cells per unit area (1000 pixels), and reported as % of control
DISCUSSIONvalues. Data are expressed as mean  SE, P  0.01.
It is generally accepted that decreases in circulating
calcium and 1,25 dihydroxyvitamin D3, and retention of
phosphate are the main systemic factors responsible for
loading on both events indistinguishable. In addition, the parathyroid hyperplasia associated with uremia. The
perturbations of serum chemistries were evident at 1 day cellular and molecular mechanisms by which these
post-surgery. Therefore, a second experiment was per- factors regulate parathyroid cell proliferation, however,
formed to allow for recovery from the surgery before remain unclear. The relationship between the calcium-
initiating the time course to examine the changes in CaR sensing receptor (CaR) and parathyroid cell prolifera-
expression and parathyroid proliferation in uremic rats tion has been investigated. Parathyroid hyperplasia is
in response to the HP diet. In protocol 2, rats were found in neonatal severe hyperparathyroidism, a disease
nephrectomized and placed on a low phosphate diet (LP; attributed to loss-of-function mutations in the CaR [11],
0.2% P, 0.5% Ca), which prevents both down-regulation and in the CaR-nullizygous mouse [12], suggesting that
of the CaR and parathyroid hyperplasia in uremic rats total loss of the CaR leads to parathyroid cell prolifera-
[7]. After 1 week on the LP diet, the rats were switched tion. Several groups have noted that the CaR expression
to the HP diet, and changes in CaR expression and para- is decreased in parathyroid gland adenomas, in hyper-
thyroid proliferation examined as in the previous proto- plastic parathyroid glands of patients with chronic renal
col. Serum chemistries, PTH and PTG weights are shown disease [1, 2], and in hyperplastic parathyroid glands of
in Table 2. Nephrectomized rats maintained on the LP uremic rats [7]. Down-regulation of the CaR is associated
diet and at each time point after being switched to the with high proliferative activity of parathyroid glands in
HP diet exhibited uremia as indicated by significant ele- patients with secondary hyperparathyroidism and in ure-
vations in serum creatinine levels compared with con- mic rats [6, 7]. In addition, NPS-R568, an allosteric en-
trols. PTH levels in nephrectomized rats kept on the hancer of the calcium-sensing receptor suppressed para-
LP diet for 1 week were not significantly different than thyroid cell proliferation in rats with renal insufficiency
controls. However, PTH levels increased significantly in [13, 14].
nephrectomized rats by 1 day of being switched to the HP Although loss-of-function mutations in the CaR have
diet and remained elevated throughout the time course. not been detected in hyperplastic glands from uremic
Parathyroid gland weights of nephrectomized rats were patients, is has been suggested that a reduction in CaR
consistently higher by 3 days on the HP diet compared expression may be an initiating event in the hyperplastic
to controls. response. To investigate the nature of the temporal rela-
Quantitation of the changes in cell proliferation (PCNA tionship between these two events, the current study
immunostaining) in relation to changes of the CaR compared the time courses for the onset of parathyroid
expression (CaR immunostaining) from protocol 2 is gland proliferation and down-regulation of the CaR in
the uremic rat model. In our initial protocol, rats wereshown in Figure 3. Again, an increase in parathyroid cell
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Table 2. Serum chemistries: Protocol 2
Creatinine ICa P
PTH PTG/body wt
Groups N mg/dL pg/mL lg/g
Controls 9 0.780.07 4.520.09 5.940.77 118 0.870.15
LP uremic control 8 1.380.23a 4.590.37 5.960.98 2018 1.030.18
1 day HP 9 1.600.21a 4.330.18b 8.693.08b 4235b 1.170.22a
2 days HP 7 1.590.19a 4.560.33 8.042.49b 6146b 1.000.24
3 days HP 9 1.650.21a 4.620.20 7.751.45a 9845a 1.180.27a
4 days HP 7 1.490.15a 4.610.25 9.931.42a 154137a 1.280.30a
7 days HP 7 1.490.41a 4.680.18b 9.192.57a 417229a 1.530.36a
14 days HP 9 1.910.31a 4.290.13a 9.201.70a 259106a 1.610.35a
Rats were made uremic and placed immediately on a low phosphate (LP) diet. After 1 week, they were switched to a high phosphate (HP) diet. Intact control
rats were fed a normal chow diet. Data are expressed as mean  SD.
a P  0.01, b P  0.05 compared to control values
being maintained on a low phosphate diet that prevents
parathyroid hyperplasia and the fall in CaR expression.
This low phosphate diet also minimizes the fall in serum
calcium and the rise in serum phosphorus observed at
1 day post-surgery. (These fluctuations, not seen in pa-
tients with slowly progressing renal disease, could have
an impact on both parathyroid cell hyperplasia and CaR
down-regulation). After 1 week on the low phosphate diet,
the rats were switched to a high phosphate diet. Within
2 days of the switch, an increase in parathyroid cell prolif-
eration was detected. CaR content, however, did not
decrease until after day 7. As in the initial experiment,
therefore, parathyroid cell proliferation preceded down-
regulation of the CaR in rats responding to the combina-
tion of renal insufficiency and dietary phosphate loading.
We and other have previously shown that down-regu-
Fig. 3. Time course of changes in PCNA () and CaR () expression lation of the CaR is associated with areas of parathyroid
for protocol 2. Uremic rats were maintained on a low phosphate (LP)
cell proliferation [6, 7]. However, as illustrated in Fig-diet for one week before being switched to a high phosphate (HP)
diet that promotes parathyroid hyperplasia. Intact control rats were ure 1, one may note that the number of cells traversing
maintained on a regular chow diet. CaR protein content was assessed the cell cycle (PCNA-positive immunostaining) in re-
by immunohistochemical staining, quantified by computer-assisted anal-
sponse to the high phosphate diet appears to be minorysis, and reported as optical density, % of control values. Cell prolifera-
tion was determined as the number of PCNA-positive cells per unit compared to the more diffuse decrease in CaR. We have
area (1000 pixels), and reported as % of control values. Data are found that when uremic rats are fed a high phosphate
expressed as mean  SE, P  0.01.
diet, the parathyroid CaR becomes down-regulated and
only returns to normal levels when the high phosphate
stimulus is withdrawn (unpublished data). In the current
study, uremic rats were fed a continuous diet of highnephrectomized and immediately placed on a high phos-
phosphate. Under these circumstances, the number of cellsphate diet. An increase in parathyroid cell proliferation
proliferating at any one time is going to appear less thanwas detected very early at 2 days post-nephrectomy. CaR
the accumulating areas of decreased CaR. Also, it is pos-expression was not changed at 2 days, but was decreased
sible that cell proliferation/dedifferentiation triggers aby 4 days post-nephrectomy. This window of time be-
cascade of events that leads (directly or indirectly) totween which changes in cell proliferation and CaR ex-
down-regulation of the CaR in surrounding cells. As dis-pression were detected was relatively small and could
cussed below, autocrine/growth factors such as trans-have merely reflected the differences in the precision of
forming growth factor- (TGF-), acidic-fibroblast growththe two measurements (that is, it is possible that it was
factor (acidic-FGF), and endothelin-1 (ET-1) have beeneasier to detect the initial increase in the cell prolifera-
found in hyperplastic parathyroid tissue. As yet, theirtion than it was to detect the initial quantitative loss of
functions on parathyroid proliferation and/or the CaRCaR). However, in a separate experiment we were able
to expand the time between these two events. In Protocol are not fully defined. If a potentiation of CaR down-
regulation does occur in surrounding cells, it would ap-2, rats were allowed to recover from nephrectomy while
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